Condition
    Strong Evidence
    Effectiveness 3/5

    Calcium for Premenstrual Syndrome (PMS)

    Calcium 1,000-1,200 mg/day is one of the better-supported nutritional interventions for PMS, reducing mood, bloating and pain symptoms.

    Overview

    Calcium is one of the few nutritional interventions for premenstrual syndrome that has survived randomised testing rather than surviving on tradition. At 1,000-1,200 mg a day it reduces the mood, bloating and pain symptoms that cluster in the luteal phase, with effect sizes that are modest per symptom but consistent across the symptom set. It is not a treatment for premenstrual dysphoric disorder, and it will not do much for a woman whose diet already supplies well over a gram of calcium daily. It is best thought of as correcting a cyclical vulnerability rather than sedating a symptom.

    Who this suits

    Women with regular cycles, recurring luteal-phase mood and physical symptoms, and a dietary calcium intake below roughly 800 mg a day.

    The clinical picture that responds best is the classic one: irritability, low mood, breast tenderness, bloating and cramping that arrive in the week or so before bleeding and lift once it starts. Improvement builds over cycles rather than within one, so the intervention needs to be judged across two to three months.

    How It Works

    Oestrogen and progesterone both influence calcium handling. Across the cycle, oestrogen fluctuation alters intestinal calcium absorption, parathyroid hormone secretion and 1,25-dihydroxyvitamin D levels, so circulating ionised calcium moves in a pattern that tracks the luteal phase. Women with premenstrual syndrome show exaggerated versions of these shifts.
    Calcium is also a direct participant in neuromuscular excitability and neurotransmitter release. Low ionised calcium raises smooth and skeletal muscle irritability and alters serotonergic signalling, which plausibly links the same deficit to cramping, breast tenderness and mood change. Repletion appears to flatten the cyclical swing rather than blunt symptoms pharmacologically.

    Key mechanisms

    Stabilises cyclical ionised calcium
    Modulates parathyroid hormone response
    Supports serotonergic signalling
    Reduces neuromuscular excitability
    Interacts with vitamin D status

    Dosing & Protocol

    The trial dose is 1,000-1,200 mg of elemental calcium daily, taken continuously rather than only in the luteal phase. Absorption falls sharply above roughly 500 mg in a single dose, so split it into two or three servings taken with food. Calcium carbonate is cheapest and absorbs well with a meal because it needs stomach acid; calcium citrate absorbs adequately without food and suits anyone on acid-suppressing medication. Count dietary calcium towards the total rather than adding a full gram on top of a dairy-rich diet.
    ScenarioDoseFormTiming
    Standard PMS protocol1,000-1,200 mg elemental dailyCalcium carbonate or citrateSplit into 2-3 doses with meals
    On acid-suppressing medication1,000 mg elemental dailyCalcium citrateSplit doses, food optional
    Dietary intake already 800+ mgTop up to 1,000-1,200 mg totalEither formOne evening dose
    Upper limit from all sources2,000-2,500 mg daily--
    1. 1

      Estimate your dietary calcium first· Before starting

      A serving of milk, yoghurt or hard cheese is roughly 200-300 mg. Supplement the gap, not the whole target.

    2. 2

      Split the dose· Daily

      Two or three servings of 400-500 mg absorb far better than one large dose.

    3. 3

      Check vitamin D status· Week 1

      Calcium absorption depends on adequate vitamin D; deficiency undermines the whole intervention.

    4. 4

      Track symptoms across cycles· Cycles 1-3

      Score mood, bloating and pain daily for two to three cycles rather than judging by impression.

    Take it every day, not just premenstrually

    The trials dosed continuously. Calcium status shifts over weeks, so luteal-phase-only dosing does not reproduce the studied intervention.

    Evidence

    The evidence base rests on randomised placebo-controlled trials in women with prospectively confirmed premenstrual syndrome, plus meta-analyses pooling them. The pattern is a reduction in total symptom score of roughly a third to a half over two to three cycles, with the clearest effects on negative affect, water retention and pain.
    Trial quality is mixed: sample sizes are mostly in the tens to low hundreds, symptom scoring instruments differ between studies, and placebo responses in premenstrual syndrome are large. Those limitations argue for calling the effect real but moderate rather than decisive.
    No studies are currently linked to this pair in our database; citations are pending review and the summary above reflects the published randomised and meta-analytic literature rather than a specific indexed record here.

    Safety

    Calcium at these doses is well tolerated. The common complaints are constipation and bloating, both dose-dependent and both usually solved by splitting the dose or switching from carbonate to citrate. Total intake from food plus supplements should stay below about 2,000-2,500 mg a day.

    Stop and seek advice if

    You have a history of calcium-containing kidney stones, hyperparathyroidism, sarcoidosis or chronic kidney disease. Supplemental calcium is not neutral in any of these.

    Interactions & Conflicts

    Calcium binds to several drug classes in the gut and reduces their absorption. The fix is almost always timing rather than avoidance: separate the doses by two to four hours.
    Interacts withSeverityMechanismAction

    References

    1. Randomised trials of calcium carbonate in premenstrual syndrome (citation pending indexing)
    2. Meta-analyses of calcium supplementation and premenstrual symptom scores (citation pending indexing)

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.